An "epitomics" platform to define and drug cancer-specific epitopes on the cell surface
Cancer therapies often lack highly specific cell-surface targets, leading to limited efficacy and off-target toxicity.
Stipple Bio provides an epitomics platform to identify and enable drugging of cancer-specific cell-surface epitopes.
Biopharma companies and oncology drug developers seeking new cancer-specific therapeutic targets.



